Inaka Pharma Private Limited

Inaka Pharma Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24303AP2022PTC121072 Incorporated 17 March 2022 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2023
₹78.82 Lakh
Latest filing
Net profit · FY 2023
₹20,523
Net margin 0.3%
EBITDA · FY 2023
₹1.67 Lakh
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Inaka Pharma Private Limited

Data last updated:

Inaka Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2022.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24303AP2022PTC121072. Its GSTIN is 37AAGCI5739K1Z2 (Andhra Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sathish Kumar Attili and Talam Radha Krishna.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 303 B – Block Aditya Fortune Towers Midhilapuri Vuda Colony Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530041.

As per the financials filed for FY 2023, the company reported a revenue of ₹78.82 Lakh. For the same year it recorded a net profit of ₹20,523 (net margin 0.3%) and EBITDA of ₹1.67 Lakh (EBITDA margin 2.1%).

Inaka Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0044831).

Company details

CIN U24303AP2022PTC121072
Registration Number 121072
Incorporation Date 17 March 2022
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-AP-10-0044831

Recognitions & Rankings of Inaka Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-AP-10-0044831

Contact details

Inaka Pharma Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. 303 B – Block Aditya Fortune Towers Midhilapuri Vuda Colony Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530041
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Inaka Pharma Private Limited, buy the company report.

Comprehensive company report
Inaka Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Inaka Pharma Private Limited

FY 2025 filings available

Inaka Pharma Private Limited reported revenue of ₹78.82 Lakh for FY 2023.

Revenue · FY 2023
₹78.82 Lakh
Net profit · FY 2023
₹20,523 margin 0.3%
EBITDA · FY 2023
₹1.67 Lakh margin 2.1%

Financial Statement Summary

MetricsFY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations₹78.82 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.67 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹20,523
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22
Profitability
EBITDA Margin2.1%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Inaka Pharma Private Limited, buy the company report.

Board of directors of Inaka Pharma Private Limited

Inaka Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sathish Kumar AttiliDirector17 Mar 20224 Years 7 MonthsCurrent
Talam Radha KrishnaDirector17 Mar 20224 Years 7 MonthsCurrent

Auditor

Inaka Pharma Private Limited is audited by MURTHY & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MURTHY & ASSOCIATESFY 2023014085S

Shareholding

The shareholding of Inaka Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Inaka Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Inaka Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Inaka Pharma Private Limited has 1 active EPFO establishment as of Apr 02, 2024.

Active EPFO establishments
1

GST

Inaka Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAGCI5739K1Z2Andhra PradeshActive13 Apr 2022

To see the full GST registrations and return filing status of Inaka Pharma Private Limited, buy the company report.

Recent activity

Inaka Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Sathish Kumar Attili was appointed as Director on 17 Mar 2022.

AGM
Inaka Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Inaka Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Appointed
Sathish Kumar Attili was appointed as Director.
Appointed
Talam Radha Krishna was appointed as Director.
Incorporation
17 Mar 2022
Inaka Pharma Private Limited was registered on 17 Mar 2022 with Roc Vijayawada & aged 4 years 7 months as per MCA records.

Frequently asked questions

Inaka Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2022 (4+ years old) and is registered under CIN U24303AP2022PTC121072.

Inaka Pharma has 2 current directors:

The latest financial statements of Inaka Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Inaka Pharma is 37AAGCI5739K1Z2, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Inaka Pharma is U24303AP2022PTC121072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Inaka Pharma was incorporated on 17 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Vijayawada.

Sathish Kumar Attili was appointed as Director on 17 Mar 2022. Talam Radha Krishna was appointed as Director on 17 Mar 2022.

Yes, Inaka Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-10-0044831).

The registered office of Inaka Pharma is at Flat No. 303 B – Block Aditya Fortune Towers Midhilapuri Vuda Colony Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530041.

Inaka Pharma operates in the pharma industry, in the drug formulation and development segment.